Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinolone derivatives as fibroblast growth factor receptor inhibitors

Quinolone derivatives as fibroblast growth factor receptor inhibitors

US Patent 10294223 · Granted May 21, 2019

Estimated economic value: $10,536,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunoproteasome inhibitors2025
Quinolone derivatives as fibroblast growth factor receptor inhibitors2024
Quinolone derivatives as fibroblast growth factor receptor inhibitors2024
Immunoproteasome inhibitors2024
Immunoproteasome inhibitors2023
Spirocyclic compounds as tryptophan hydroxylase inhibitors2023
Compounds and methods for modulating Bruton's Tyrosine Kinase2022
Compounds and methods for modulating adenosine A2B receptor and adenosine A2A re2022
Immunoproteasome inhibitors2022
Immunoproteasome inhibitors2021
Quinolone derivatives as fibroblast growth factor receptor inhibitors2021
Quinolone derivatives as fibroblast growth factor receptor inhibitors2021